Послушайте подкаст CEConversations

Treating Metastatic HER2-negative Breast Cancer: Oncology Nursing Approaches to Improve Patient Quality of Life	CEConversations	49:37
Advancing Cervical Cancer Care: Navigating New Therapies, Guidelines, and Patient-Centric Approaches	CEConversations	48:09
MEK Inhibitors in Neurofibromatosis Type 1: Latest Advances and Real-World Applications in NF1-PN Management	CEConversations	63:44
All Hands on Deck: Spotlight on Clinical Advances in Relapsed/Refractory Diffuse Large B-Cell Lymphoma	CEConversations	51:06
Advancements in the Management of Relapsed/Refractory B-Cell Malignancies – Integrating Recent Data into Practice to Improve Outcomes	CEConversations	51:52
All Hands on Deck: A Focus on Current and Emerging Treatment Options in the Frontline Setting for Peripheral T-cell Lymphoma	CEConversations	41:21
All Hands on Deck – Utilizing JAK Inhibitors in Myelofibrosis Care: Evidence, Timing, and Strategic Approaches	CEConversations	46:40
All Hands on Deck in Cervical Cancer Care: Screening, Treatment, and Equity Strategies to Improve Patient Lives	CEConversations	60:36
Tailoring Patient Care Using Novel Agents in Metastatic Urothelial Carcinoma: Strategies for the Interprofessional Team	CEConversations	78:19
Advancements and Applications of Antibody Drug Conjugates in HER2-Negative Breast Cancer	CEConversations	50:54
Transforming Metastatic Breast Cancer Management: Harnessing the Power of Antibody-Drug Conjugate Therapies	CEConversations	93:21
Navigating New Waters for Advanced or Recurrent Endometrial Cancer	CEConversations	66:48
Cancer-Associated VTE: Balancing Risk and Reward with Modern Anticoagulation	CEConversations	50:27
Actionable Strategies in Community Oncology to Achieve Equity in Triple-Negative Breast Cancer	CEConversations	54:13
Primary Care Perspectives on Obesity: Embracing Novel Agents to Optimize Patient Outcomes	CEConversations	37:03
Meeting Complex Challenges in Proteinuric Glomerular Disease: An Expert Review of Emerging Data and Novel Therapeutics for IgA Nephropathy	CEConversations	56:24
Bridging Chasms in Bladder Cancer Care: An Expert Case-based Review of Treatment Selection and Sequencing in an Era of Therapeutic Novelty	CEConversations	90:56
Nephrology Nursing Insights for Managing Chronic Kidney Disease–associated Pruritus: Embracing Evolving Data and Emerging Agents to Optimize Outcomes	CEConversations	41:04
Navigating Novel Terrain in Anemia of Chronic Kidney Disease: A Patient-centric Review of Disease State, Current Chasms in Care, and the Future Promise of HIF-PH Inhibition	CEConversations	76:11
Nephrology Nurse Viewpoints on In-hospital Hyperkalemia Management: Improving Patient Outcomes in Acute Care Settings with Novel Potassium Binders	CEConversations	57:39
Harnessing the Power of Immunotherapy in HCC and BTC: An Expert Exploration of the Past, Present, and Future of Checkpoint Inhibition	CEConversations	62:45
IV Iron Expert Exchange: Data-driven Debates on the Revolutionary Role of IV Iron in Heart Failure	CEConversations	96:50
Pulmonology Perspectives on Biomarker Testing in NSCLC: Multidisciplinary Management in an Era of Rapid Change	CEConversations	107:28
Optimizing Early Breast Cancer Outcomes in the Community Setting: An Expert Review of Emerging Therapies and Evolving Standards of Care in HR+/HER2- Disease	CEConversations	61:59
Clinical Advances in Ovarian Cancer: Exploring the Expanding Role of PARP Inhibitors in the Treatment Paradigm	CEConversations	40:56
Overcoming Pediatric Iron Deficiency Anemia with IV Iron: Interprofessional Approaches to Integrating New Data, Using Novel Agents, and Optimizing Care	CEConversations	53:32
Optimizing Cancer-related Anemia Outcomes in the Community Setting: Interprofessional Approaches and Evidence-supported Strategies for Improving Care with Intravenous Iron	CEConversations	49:32
New Horizons in Unresectable Stage III NSCLC: A Case-based Exploration of Evolving Data and the Emergence of Immunotherapy	CEConversations	60:04
Breaking the Cycle in Cardiorenal Anemia Syndrome: The Practice-changing Role of IV Iron at the CKD–Heart Failure Interface	CEConversations	62:15
2022 EGFR+ Lung Cancer Rapid Recap: The Evolving State of the Science in EGFR+ NSCLC—A Closer Look at the Paradigm-Shifting Synergy of Safety, Efficacy, and Equitable Access	CEConversations	71:33
Overcoming Disparity with Novelty in Triple-Negative Breast Cancer: Community Oncology Perspectives on Promoting Equity and Improving Clinical Outcomes	CEConversations	50:21
Advancing Therapeutic Paradigms for Ovarian Cancer in The Era of PARP Inhibitors: A Guide for The Oncology Nurse	CEConversations	81:08
Targeting Unmet Patient Needs in Diffuse Large B-Cell Lymphoma (DLBCL): Emerging Strategies for the Interprofessional Healthcare Team	CEConversations	47:17
Interprofessional Perspectives on the Evolving Heart Failure Treatment Paradigm: Harnessing Novel Therapeutics to Optimize Outcomes & Overcome Disparities in Care	CEConversations	38:32
Infusing Renewed Hope into Cancer-related Anemia with Intravenous Iron: An Expert-Led Exploration of Recent and Emerging Trial Data and Current Guideline Recommendations	CEConversations	46:27
The Shot Heard 'Round the World: Vaccinating the Pandemic	CEConversations	33:32
Restoring Normalcy via the Power of Immunology: Foundational Principles and Practical Questions	CEConversations	35:20
COVID-19: What We Know About the Virus & the Disease	CEConversations	34:16

Treating Metastatic HER2-negative Breast Cancer: Oncology Nursing Approaches to Improve Patient Quality of Life

CEConversations

49:37

Advancing Cervical Cancer Care: Navigating New Therapies, Guidelines, and Patient-Centric Approaches

CEConversations

48:09

MEK Inhibitors in Neurofibromatosis Type 1: Latest Advances and Real-World Applications in NF1-PN Management

CEConversations

63:44

All Hands on Deck: Spotlight on Clinical Advances in Relapsed/Refractory Diffuse Large B-Cell Lymphoma

CEConversations

51:06